GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Linc AB (OSTO:LINC) » Definitions » EBIT per Share

Linc AB (OSTO:LINC) EBIT per Share : kr27.26 (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Linc AB EBIT per Share?

Linc AB's EBIT per Share for the three months ended in Sep. 2024 was kr-0.27. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was kr27.26.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Linc AB's EBIT per Share or its related term are showing as below:

OSTO:LINC's 3-Year EBIT Growth Rate is not ranked *
in the Asset Management industry.
Industry Median: 6.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Linc AB's EBIT for the three months ended in Sep. 2024 was kr-15.81 Mil.


Linc AB EBIT per Share Historical Data

The historical data trend for Linc AB's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Linc AB EBIT per Share Chart

Linc AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT per Share
Get a 7-Day Free Trial 9.81 15.80 -0.73 -15.47 11.50

Linc AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 8.46 1.11 17.96 -0.27

Linc AB EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Linc AB's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBIT per Share(A: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=666.1/57.910
=11.50

Linc AB's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

EBIT per Share(Q: Sep. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-15.806/57.910
=-0.27

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr27.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Linc AB  (OSTO:LINC) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Linc AB EBIT per Share Related Terms

Thank you for viewing the detailed overview of Linc AB's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Linc AB Business Description

Traded in Other Exchanges
Address
Strandvagen 7A, Stockholm, SWE, 114 51
Linc AB is an investor in product-oriented companies in the Nordic Life Science industry. It mainly invests in and develops small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals.